July 10, 2019
RAPT Therapeutics, Inc. (formerly called FLX Bio Inc.) raised more than $86 million in its initial public offering earlier this month. Brian Wong, M.D., Ph.D., (Tri-Institutional MD-PhD graduating class of 2001) leads RAPT as both President and CEO of the company.
To read more, visit SF Business times for their article, for their article about RAPT and the successful IPO.
Brian Wong
Category:
- Alumni